Get started
VivoSim Labs, Inc.VivoSim Labs, Inc.VivoSim Labs, Inc.

VivoSim Labs, Inc.

No trades
No trades
OverviewFinancialsNewsCommunityTechnicalsForecastsSeasonals
Full chart
Full chart

Compare with VivoSim Labs, Inc.



Key stats


Market capitalization
‪2.02 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−5.3519 USD
Net income (FY)
‪−13.84 M‬ USD
Revenue (FY)
‪131.00 K‬ USD
Shares float
‪3.05 M‬
Beta (1Y)
2.35

Latest earnings


Last report date
Jul 14, 2026
Report period
Q4 2025

Employees


Employees (FY)
15
Change (1Y)
+2+15.38%
Revenue / Employee (1Y)
‪8.73 K‬ USD
Net income / Employee (1Y)
‪−922.87 K‬ USD

Profile


Sector
Health Technology
Industry
Biotechnology
CEO
Keith Murphy
Website
vivosim.ai
Headquarters
San Diego
Founded
2012
ISIN
US68620A3023
CUSIP
68620A302
FIGI
BBG001M8GFD0
Identifiers
ISIN US68620A3023
CFI code
ESVUFR
VivoSim Labs, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


The current price of VIVS is 0.4500 USD — it has decreased by −12.80% in the past 24 hours. Watch VivoSim Labs, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange VivoSim Labs, Inc. stocks are traded under the ticker VIVS.
VIVS stock has fallen by −43.33% compared to the previous week, the month change is a −56.10% fall, over the last year VivoSim Labs, Inc. has showed a −76.41% decrease.
VIVS reached its all-time high on Nov 18, 2013 with the price of 786,240.0000 USD, and its all-time low was 0.4417 USD and was reached on Jul 21, 2026. View more price dynamics on VIVS chart.
See other stocks reaching their highest and lowest prices.
VIVS stock is 28.73% volatile and has beta coefficient of 2.35. Track VivoSim Labs, Inc. stock price on the chart and check out the list of the most volatile stocks — is VivoSim Labs, Inc. there?
Today VivoSim Labs, Inc. has the market capitalization of ‪2.14 M‬, it has decreased by −28.42% over the last week.
Yes, you can track VivoSim Labs, Inc. financials in yearly and quarterly reports right on TradingView.
VivoSim Labs, Inc. is going to release the next earnings report on Aug 6, 2026. Keep track of upcoming events with our Earnings Calendar.
VIVS net income for the last quarter is ‪−5.76 M‬ USD, while the quarter before that showed ‪−2.69 M‬ USD of net income which accounts for 0.00% change. Track more VivoSim Labs, Inc. financial stats to get the full picture.
No, VIVS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 21, 2026, the company has 15 employees. See our rating of the largest employees — is VivoSim Labs, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VivoSim Labs, Inc. EBITDA is ‪−11.27 M‬ USD, and current EBITDA margin is ‪−8.60 K‬%. See more stats in VivoSim Labs, Inc. financial statements.
Like other stocks, VIVS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VivoSim Labs, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VivoSim Labs, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VivoSim Labs, Inc. stock shows the sell signal. See more of VivoSim Labs, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.